CLOs on the Move

Press Ganey

www.pressganey.com

 
For nearly 30 years, Press Ganey`s mission has been to support health care providers in understanding and improving the entire patient experience. As a strategic business partner to more than 10,000 health care organizations across the country and across the continuum of care, we are the leader in helping create continuous, sustainable improvement. Headquartered in South Bend, Indiana, Press Ganey serves clients nationwide with locally based teams of associates to ensure strong client connections and relationships. As a result, Press Ganey is acutely aware of the challenges and opportunities unique to specific providers and their communities. Our associates are professionals, ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details
Amy Compton-Phillips
EVP, Chief Medical Officer Profile

Similar Companies

Aural Analytics

We build applications that use speech and fine motor to detect subtle changes in brain health. We are rooted in neuroscience with an award winning, first to market technology platform that turns the devices we use every day into objective brain health monitors.

Indiana Perinatal Network Inc

Indiana Perinatal Network Inc is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Terumo Medical Corp

Terumo Medical Corp is a Somerset, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Therapy Workforce

Therapy Workforce is a Newark, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Braxia Scientific

Braxia Scientific is a medical research company with clinics that provide innovative ketamine treatments for persons with depression and related disorders. Through its medical solutions, Braxia aims to reduce the illness burden of brain-based disorders, such as major depressive disorder among others. Braxia is primarily focused on (i) owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and (ii) research activities related to discovering and commercializing novel drugs and delivery methods. Braxia seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. Through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., Braxia currently operates multidisciplinary community-based clinics offering rapid-acting treatments for depression located in Mississauga, Toronto, Kitchener-Waterloo, Ottawa, and Montreal.